Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.44 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.44 |
| ▸ | ABCG2 | Q9UNQ0 | 6/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1937965 | 0.93 | ABCG2 (0.54) | MAOAMAOBCYP2C9CYP2C19ABCG2 | |
| SCHEMBL2493332 | 0.88 | MEN1 (0.42) | MAOAMAOBCYP2C9CYP2C19CYP19A1 | |
| SCHEMBL1938572 | 0.86 | MAPT (0.50) | MAOAMAOBCYP2C9CYP2C19SLC5A1 | |
| SCHEMBL5084410 | 0.80 | MAOA (0.45) | MAOAMAOBCYP2C9CYP2C19CYP19A1 | |
| SCHEMBL23849510 | 0.79 | ABCB1 (0.41) | ABCB1 | |
| SCHEMBL1726653 | 0.78 | MAPT (0.37) | SLC5A1SLC5A2ABCG2NFKB1DPP4 | |
| SCHEMBL30064673 | 0.77 | ABCG2 (0.54) | ABCG2CYP3A4MAPTKMT2AHSD17B10 | |
| SCHEMBL4742903 | 0.76 | CYP3A4 (0.37) | CYP3A4MAPTUSP2 | |
| SCHEMBL1844264 | 0.76 | ABCB1 (0.34) | ABCB1 | |
| SCHEMBL28098802 | 0.74 | CYP3A4 (0.48) | MAOAMAOBCYP2C9CYP2C19CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10695283-B2 | Extract of Greyia radlkoferi and use thereof | UNIVERSITY OF PRETORIA (ZA) | 2020-06-30 | — | — | US | claimed |
| US-20180071204-A1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | UNIVERSITY OF KWAZULU-NATAL (ZA) | 2018-03-15 | — | — | US | claimed |
| EP-2849768-B1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | UNIV PRETORIA (ZA) | 2016-06-01 | — | — | EP | claimed |
| US-20150118337-A1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | UNIVERSITY OF PRETORIA (ZA) | 2015-04-30 | — | — | US | claimed |
| US-12569530-B2 | Tannin-based antiproliferative pharmaceutical | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2026-03-10 | — | — | US | disclosed |
| US-12453799-B1 | Bioadhesive for medical and dental applications | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2025-10-28 | — | — | US | disclosed |
| US-20250249063-A1 | METHOD FOR TREATING ORAL CANCER | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-08-07 | — | — | US | disclosed |
| US-12318422-B2 | Tannin-based antiproliferative pharmaceutical | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-06-03 | — | — | US | disclosed |
| US-20240293492-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-09-05 | — | — | US | disclosed |
| US-20230210931-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-07-06 | — | — | US | disclosed |
| US-11376570-B1 | Method of forming copper oxide-on-copper nanomaterial catalyst mesh | KING ABDULAZIZ UNIVERSITY (SA) | 2022-07-05 | — | — | US | disclosed |
| US-11311492-B1 | Carbon nanomedicine with natural ligands | KING ABDULAZIZ UNIVERSITY (SA) | 2022-04-26 | — | — | US | disclosed |
| US-20150118337-A1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | UNIVERSITY OF PRETORIA (ZA) | 2015-04-30 | — | — | US | disclosed |
| CN-104582713-A | Grignard family feijie extract and application thereof | UNIV PRETORIA | 2015-04-29 | — | — | CN | disclosed |
| EP-2849768-A1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | University of Pretoria (ZA) | 2015-03-25 | — | — | EP | disclosed |
| EP-2849768-A1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | University of Pretoria (ZA) | 2015-03-25 | — | — | EP | disclosed |
| US-20140023721-A1 | METHOD OF EXTRACTING ACTIVE MOLECULES FROM NATURAL RESINS AND USE THEREOF | RODE PHARMA S.R.L. (IT) | 2014-01-23 | — | — | US | disclosed |
| WO-2013171720-A1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | UNIVERSITY OF PRETORIA (ZA) | 2013-11-21 | — | — | WO | disclosed |
| WO-2013171720-A1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | UNIVERSITY OF PRETORIA (ZA) | 2013-11-21 | — | — | WO | disclosed |
| WO-2008100977-A2 | CARBAMATES THERAPEUTIC RELEASE AGENTS AS AMIDASE INHIBITORS | N.V. ORGANON (NL) | 2008-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250249063-A1 | METHOD FOR TREATING ORAL CANCER | UGGT1, G6PD, UGT1A3 | MAOA 3217/4885MAOB 4135/4885CYP2C9 1260/4885 |
| US-20240293492-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | UGGT1, G6PD, UGDH | MAOA 3285/4885MAOB 4088/4885CYP2C9 2611/4885 |
| US-12569530-B2 | Tannin-based antiproliferative pharmaceutical | SLC2A3, SLC2A1, SLC2A8 | MAOA 3606/4885MAOB 4076/4885CYP2C9 1523/4885 |
| US-20230210931-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | UGGT1, G6PD, UGDH | MAOA 3285/4885MAOB 4088/4885CYP2C9 2611/4885 |
| US-12318422-B2 | Tannin-based antiproliferative pharmaceutical | UGGT1, G6PD, UGDH | MAOA 3285/4885MAOB 4088/4885CYP2C9 2611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.